Conditions: Atopic Dermatitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 142
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether OC000459 is in reducing disease severity and preventing flares in people with moderate to severe atopic dermatitis (AD).

Detailed description:
The study will include patients with a Th2 high eosinophilic phenotype who typically have more severe disease and are prone to flare.

Arms:
arm 1: 50 mg orally once a day arm 2: Orally once a day

Interventions: intervention 1: OC000459
Intervention descriptions: intervention 1: Oral CRTH2 antagonist

Protocol document: